首页 > 最新文献

Diabetology International最新文献

英文 中文
Longitudinal monitoring of urinary C-peptide levels following discontinuation of sacubitril/valsartan in a type 2 diabetes patient: a case report and literature review. 1例2型糖尿病患者停用苏比里尔/缬沙坦后尿c肽水平的纵向监测:1例报告和文献综述
IF 1.3 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-03-31 eCollection Date: 2025-07-01 DOI: 10.1007/s13340-025-00816-y
Keiichiro Kondo, Hiroto Minamino, Takaaki Murakami, Emi Okamura, Takuro Hakata, Yohei Ueda, Daisuke Taura, Daisuke Yabe

We report two cases of diabetes mellitus treated with sacubitril/valsartan, whose urinary C-peptide dynamics exhibited significant difference. The first case is an 84-year-old Japanese man with type 2 diabetes and hypertension who exhibited significantly elevated urinary C-peptide levels during treatment with sacubitril/valsartan, an angiotensin receptor-neprilysin inhibitor (ARNi). Despite normal serum C-peptide levels, his urinary C-peptide excretion was disproportionately high, suggesting that sacubitril/valsartan may have altered C-peptide clearance through neprilysin inhibition. The discontinuation of sacubitril/valsartan demonstrated gradual decline of urinary C-peptide levels, although they remained elevated compared to serum ones. Daily longitudinal monitoring of urinary C-peptide revealed marked fluctuations of its levels, indicating a prolonged and potentially complex effect of neprilysin inhibition on C-peptide excretion. Additionally, we observed a corresponding decrease in atrial natriuretic peptide (ANP) levels after discontinuation of sacubitril/valsartan, further supporting the role of neprilysin inhibition in altering peptide metabolism. In contrast, the second case involves a 78-year-old Japanese woman with insulin-dependent type 1 diabetes and undetectable serum C-peptide levels. In her case, urinary C-peptide levels remained undetectable despite ARNi therapy. These cases highlight the need for careful clinical interpretation of urinary C-peptide levels in patients receiving neprilysin inhibitors. When evaluating pancreatic β-cell function using urinary C-peptide levels under ARNi therapy, it is crucial to consider extended monitoring of urinary C-peptide levels, the duration of drug withdrawal, and serum C-peptide levels to ensure accurate assessment.

我们报告两例糖尿病患者用苏比里尔/缬沙坦治疗,其尿c肽动力学表现出显著差异。第一个病例是一名84岁的日本男性2型糖尿病和高血压患者,他在接受血管紧张素受体-neprilysin抑制剂(ARNi)苏比里尔/缬沙坦治疗期间尿c肽水平明显升高。尽管血清c肽水平正常,但尿c肽排泄异常高,提示sacubitril/缬沙坦可能通过抑制neprilysin改变了c肽清除。停用苏比里尔/缬沙坦后尿c肽水平逐渐下降,但仍高于血清c肽水平。每日对尿c肽的纵向监测显示其水平有明显的波动,表明奈普利菌素对c肽排泄的抑制作用是长期的,可能是复杂的。此外,我们观察到停用苏比里尔/缬沙坦后,心房钠尿肽(ANP)水平相应下降,进一步支持奈普利素抑制在改变肽代谢中的作用。相比之下,第二个病例涉及一名78岁的日本妇女,患有胰岛素依赖型1型糖尿病,血清c肽水平未检测到。在她的病例中,尽管ARNi治疗,尿c肽水平仍未检测到。这些病例强调需要仔细的临床解释尿c肽水平的患者接受奈普利素抑制剂。在ARNi治疗下使用尿c肽水平评估胰腺β细胞功能时,重要的是要考虑延长监测尿c肽水平、停药时间和血清c肽水平,以确保准确评估。
{"title":"Longitudinal monitoring of urinary C-peptide levels following discontinuation of sacubitril/valsartan in a type 2 diabetes patient: a case report and literature review.","authors":"Keiichiro Kondo, Hiroto Minamino, Takaaki Murakami, Emi Okamura, Takuro Hakata, Yohei Ueda, Daisuke Taura, Daisuke Yabe","doi":"10.1007/s13340-025-00816-y","DOIUrl":"10.1007/s13340-025-00816-y","url":null,"abstract":"<p><p>We report two cases of diabetes mellitus treated with sacubitril/valsartan, whose urinary C-peptide dynamics exhibited significant difference. The first case is an 84-year-old Japanese man with type 2 diabetes and hypertension who exhibited significantly elevated urinary C-peptide levels during treatment with sacubitril/valsartan, an angiotensin receptor-neprilysin inhibitor (ARNi). Despite normal serum C-peptide levels, his urinary C-peptide excretion was disproportionately high, suggesting that sacubitril/valsartan may have altered C-peptide clearance through neprilysin inhibition. The discontinuation of sacubitril/valsartan demonstrated gradual decline of urinary C-peptide levels, although they remained elevated compared to serum ones. Daily longitudinal monitoring of urinary C-peptide revealed marked fluctuations of its levels, indicating a prolonged and potentially complex effect of neprilysin inhibition on C-peptide excretion. Additionally, we observed a corresponding decrease in atrial natriuretic peptide (ANP) levels after discontinuation of sacubitril/valsartan, further supporting the role of neprilysin inhibition in altering peptide metabolism. In contrast, the second case involves a 78-year-old Japanese woman with insulin-dependent type 1 diabetes and undetectable serum C-peptide levels. In her case, urinary C-peptide levels remained undetectable despite ARNi therapy. These cases highlight the need for careful clinical interpretation of urinary C-peptide levels in patients receiving neprilysin inhibitors. When evaluating pancreatic β-cell function using urinary C-peptide levels under ARNi therapy, it is crucial to consider extended monitoring of urinary C-peptide levels, the duration of drug withdrawal, and serum C-peptide levels to ensure accurate assessment.</p>","PeriodicalId":11340,"journal":{"name":"Diabetology International","volume":"16 3","pages":"580-585"},"PeriodicalIF":1.3,"publicationDate":"2025-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12209063/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144552624","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Periodontal disease and the incident risk of diabetes mellitus in Japanese men and women: a 12-year cohort study. 日本男性和女性牙周病和糖尿病发生风险:一项为期12年的队列研究
IF 1.3 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-03-29 eCollection Date: 2025-07-01 DOI: 10.1007/s13340-025-00815-z
Kazuka Yoneda, Masaru Sakurai, Yoshiyuki Soyama, Motoko Nakashima, Yuko Morikawa, Teruhiko Kido, Yuchi Naruse, Masao Ishizaki, Hideaki Nakagawa

Aims/introduction: This study assessed the association between periodontal disease and the development of diabetes mellitus, as well as the effects of sex differences and obesity on this association.

Materials and methods: The study included 4051 employees (2497 men and 1554 women) aged 35-55 years at a metal product manufacturing company in Japan. Periodontal disease was assessed using the Community Periodontal Index. Diabetes mellitus was determined based on annual health checkups.

Results: The prevalence of periodontal disease was 36.9% (41.9% in men and 29.5% in women). During the 12-year follow-up, 229 participants developed diabetes. The cumulative incidence rates (per 1000 person-years) were 10.1 for all participants, 7.8 for those without periodontal disease, and 14.5 for those with periodontal disease. The multivariate-adjusted hazard ratio (HR) for diabetes incidence in the periodontal disease group was 1.36 (95% confidence interval: 1.04-1.78); this was significantly higher than in the non-periodontal disease group. In men, the multivariate-adjusted HR for diabetes incidence was significantly higher in the periodontal disease group, at 1.37 (1.02-1.83), than in the non-periodontal disease group. No significant association was detected in women. When stratified according to sex and obesity status, the non-obese male group showed a significantly higher HR for diabetes incidence in the periodontal disease group (1.75 [1.15-2.66]) compared with the non-periodontal disease group.

Conclusions: This 12-year prospective cohort study demonstrated that periodontal disease significantly increased the risk of diabetes; the association was more pronounced in men, particularly non-obese men.

Supplementary information: The online version contains supplementary material available at 10.1007/s13340-025-00815-z.

目的/介绍:本研究评估了牙周病与糖尿病发展之间的关系,以及性别差异和肥胖对这种关系的影响。材料与方法:本研究包括日本一家金属制品制造公司的4051名员工(男性2497名,女性1554名),年龄在35-55岁之间。使用社区牙周指数评估牙周病。糖尿病是根据年度健康检查确定的。结果:牙周病患病率为36.9%,其中男性41.9%,女性29.5%。在12年的随访中,229名参与者患上了糖尿病。所有参与者的累积发病率(每1000人年)为10.1,无牙周病者为7.8,有牙周病者为14.5。牙周病组糖尿病发病率的多变量校正危险比(HR)为1.36(95%可信区间:1.04-1.78);这明显高于非牙周病组。在男性中,牙周病组糖尿病发病率的多变量调整HR显著高于非牙周病组,为1.37(1.02-1.83)。在女性中未发现显著相关性。按性别和肥胖状况分层,非肥胖男性牙周病组糖尿病发病率HR(1.75[1.15-2.66])明显高于非牙周病组。结论:这项为期12年的前瞻性队列研究表明,牙周病显著增加糖尿病的风险;这种关联在男性中更为明显,尤其是不肥胖的男性。补充信息:在线版本包含补充资料,下载地址为10.1007/s13340-025-00815-z。
{"title":"Periodontal disease and the incident risk of diabetes mellitus in Japanese men and women: a 12-year cohort study.","authors":"Kazuka Yoneda, Masaru Sakurai, Yoshiyuki Soyama, Motoko Nakashima, Yuko Morikawa, Teruhiko Kido, Yuchi Naruse, Masao Ishizaki, Hideaki Nakagawa","doi":"10.1007/s13340-025-00815-z","DOIUrl":"10.1007/s13340-025-00815-z","url":null,"abstract":"<p><strong>Aims/introduction: </strong>This study assessed the association between periodontal disease and the development of diabetes mellitus, as well as the effects of sex differences and obesity on this association.</p><p><strong>Materials and methods: </strong>The study included 4051 employees (2497 men and 1554 women) aged 35-55 years at a metal product manufacturing company in Japan. Periodontal disease was assessed using the Community Periodontal Index. Diabetes mellitus was determined based on annual health checkups.</p><p><strong>Results: </strong>The prevalence of periodontal disease was 36.9% (41.9% in men and 29.5% in women). During the 12-year follow-up, 229 participants developed diabetes. The cumulative incidence rates (per 1000 person-years) were 10.1 for all participants, 7.8 for those without periodontal disease, and 14.5 for those with periodontal disease. The multivariate-adjusted hazard ratio (HR) for diabetes incidence in the periodontal disease group was 1.36 (95% confidence interval: 1.04-1.78); this was significantly higher than in the non-periodontal disease group. In men, the multivariate-adjusted HR for diabetes incidence was significantly higher in the periodontal disease group, at 1.37 (1.02-1.83), than in the non-periodontal disease group. No significant association was detected in women. When stratified according to sex and obesity status, the non-obese male group showed a significantly higher HR for diabetes incidence in the periodontal disease group (1.75 [1.15-2.66]) compared with the non-periodontal disease group.</p><p><strong>Conclusions: </strong>This 12-year prospective cohort study demonstrated that periodontal disease significantly increased the risk of diabetes; the association was more pronounced in men, particularly non-obese men.</p><p><strong>Supplementary information: </strong>The online version contains supplementary material available at 10.1007/s13340-025-00815-z.</p>","PeriodicalId":11340,"journal":{"name":"Diabetology International","volume":"16 3","pages":"528-537"},"PeriodicalIF":1.3,"publicationDate":"2025-03-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12209127/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144552629","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Optimal foot skin care for diabetes-related foot ulcer prevention: scoping review. 糖尿病相关足部溃疡预防的最佳足部皮肤护理:范围综述。
IF 1.3 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-03-27 eCollection Date: 2025-07-01 DOI: 10.1007/s13340-025-00814-0
Makoto Oe, Amika Yamada, Erlin Ifadah

Aim: In patients with diabetes, autonomic neuropathy leads to reduced sweating, which can lead to dry skin, and if the condition worsens, these can progress from foot fissures to ulcers. Although foot skin care is important in patients with diabetes to prevent diabetes-related foot ulcers, there are no detailed guidelines that provide specific methodology for achieving this goal. This scoping review aimed to clarify what is known in the literature regarding foot skin care for dry skin for patients with diabetes and propose optimal foot skin care to help prevent diabetes-related foot ulcers.

Methods: Literature databases were searched and two independent researchers screened the articles according to the inclusion criteria and then extracted the data. To be included in the analysis, all reports had to be original articles/case studies, studies involving human subjects, and studies on foot skin care for dry skin for patients with diabetes.

Results: Seven studies met the inclusion criteria. Findings showed that application of a moisturizer, especially a cream containing urea or a cream containing 15% glycerol, liquid, and 10% soft paraffin twice a day for at least two weeks, could help relieve dry feet.

Conclusion: Establishing optimal foot skin care for patients with diabetes may require further studies that examine the frequency and long-term effects of foot skin care interventions, with the ultimate outcome focused on the development of diabetes-related foot ulcers.

目的:在糖尿病患者中,自主神经病变导致出汗减少,这可能导致皮肤干燥,如果病情恶化,这些可能从足裂发展到溃疡。虽然足部皮肤护理对糖尿病患者预防糖尿病相关足部溃疡很重要,但没有详细的指南提供实现这一目标的具体方法。本综述旨在澄清文献中已知的关于糖尿病患者皮肤干燥的足部皮肤护理,并提出最佳的足部皮肤护理,以帮助预防糖尿病相关的足部溃疡。方法:检索文献数据库,由两名独立研究人员根据纳入标准对文章进行筛选,提取数据。要纳入分析,所有报告必须是原创文章/案例研究,涉及人类受试者的研究,以及糖尿病患者皮肤干燥的足部皮肤护理研究。结果:7项研究符合纳入标准。研究结果表明,使用保湿霜,特别是含有尿素的霜或含有15%甘油、液体和10%软石蜡的霜,每天两次,持续至少两周,可以帮助缓解脚干。结论:为糖尿病患者建立最佳的足部皮肤护理可能需要进一步的研究,检查足部皮肤护理干预的频率和长期效果,最终的结果将集中在糖尿病相关足部溃疡的发展上。
{"title":"Optimal foot skin care for diabetes-related foot ulcer prevention: scoping review.","authors":"Makoto Oe, Amika Yamada, Erlin Ifadah","doi":"10.1007/s13340-025-00814-0","DOIUrl":"10.1007/s13340-025-00814-0","url":null,"abstract":"<p><strong>Aim: </strong>In patients with diabetes, autonomic neuropathy leads to reduced sweating, which can lead to dry skin, and if the condition worsens, these can progress from foot fissures to ulcers. Although foot skin care is important in patients with diabetes to prevent diabetes-related foot ulcers, there are no detailed guidelines that provide specific methodology for achieving this goal. This scoping review aimed to clarify what is known in the literature regarding foot skin care for dry skin for patients with diabetes and propose optimal foot skin care to help prevent diabetes-related foot ulcers.</p><p><strong>Methods: </strong>Literature databases were searched and two independent researchers screened the articles according to the inclusion criteria and then extracted the data. To be included in the analysis, all reports had to be original articles/case studies, studies involving human subjects, and studies on foot skin care for dry skin for patients with diabetes.</p><p><strong>Results: </strong>Seven studies met the inclusion criteria. Findings showed that application of a moisturizer, especially a cream containing urea or a cream containing 15% glycerol, liquid, and 10% soft paraffin twice a day for at least two weeks, could help relieve dry feet.</p><p><strong>Conclusion: </strong>Establishing optimal foot skin care for patients with diabetes may require further studies that examine the frequency and long-term effects of foot skin care interventions, with the ultimate outcome focused on the development of diabetes-related foot ulcers.</p>","PeriodicalId":11340,"journal":{"name":"Diabetology International","volume":"16 3","pages":"520-527"},"PeriodicalIF":1.3,"publicationDate":"2025-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12209484/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144552628","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring the association between self-efficacy for locomotor function and diabetes status in older females: a pilot study. 老年女性运动功能自我效能感与糖尿病状态的相关性研究。
IF 1.3 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-03-25 eCollection Date: 2025-07-01 DOI: 10.1007/s13340-025-00813-1
Fumiya Aizawa, Toshihiro Kawae, Akihiro Kakuda, Tomoyasu Ishiguro, Nobuichi Kuribayashi, Junji Kobayashi

Introduction: Older adults with diabetes often experience a decline in locomotor functions, such as stair climbing and walking, which are important for activities of daily living (ADL). Furthermore, individuals with low Self-Efficacy for Locomotor Function (SELF) are at a higher risk of requiring locomotor assistance. This study explored the relationship between diabetes and SELF in older females.

Methods: This study included 45 females (15 non-diabetes, 30 diabetes) aged 65 years and over without ADL impairment in our clinic. SELF was measured by walking and stair climbing. Physical function was measured by hand grip strength, knee extension force (KEF), and KEF divided by bodyweight (%KEF).

Results: The SELF of stair climbing was significantly lower in the diabetes mellitus group than in the non-diabetes mellitus group (p = 0.009), whereas the SELF of walking was not significantly different (p = 0.351). Diabetes status remained a significant factor in the SELF of stair climbing after adjusting for body mass index, orthopedic disease, and %KEF.

Discussion: Stair climbing is one of the most vigorous ADLs performed by older adults, and this result may be due to the fact that stair climbing is a more vigorous activity than walking. Furthermore, the results of this study suggest that other factors (physical function other than %KEF and handgrip strength, psychological factors) related to diabetes may be more important than %KEF in older females.

Conclusions: SELF for stair climbing in older females was lower in those with diabetes, indicating that diabetes status significantly influenced their perceived ability to perform this task.

Supplementary information: The online version contains supplementary material available at 10.1007/s13340-025-00813-1.

老年糖尿病患者通常会出现运动功能下降,如爬楼梯和行走,这对日常生活活动(ADL)很重要。此外,运动功能自我效能低的个体需要运动辅助的风险更高。本研究探讨老年女性糖尿病与SELF之间的关系。方法:本研究纳入我院65岁及以上无ADL功能障碍的女性45例(非糖尿病15例,糖尿病30例)。通过步行和爬楼梯来测量SELF。通过手握力、膝关节伸长力(KEF)和KEF除以体重(%KEF)来测量身体功能。结果:糖尿病组爬楼梯的SELF显著低于非糖尿病组(p = 0.009),而步行的SELF差异无统计学意义(p = 0.351)。在调整体重指数、骨科疾病和%KEF后,糖尿病状态仍然是影响爬楼梯自我的重要因素。讨论:爬楼梯是老年人进行的最剧烈的日常活动之一,这一结果可能是因为爬楼梯比走路更剧烈。此外,本研究的结果表明,在老年女性中,与糖尿病相关的其他因素(身体功能,而不是%KEF和握力,心理因素)可能比%KEF更重要。结论:患有糖尿病的老年女性爬楼梯的自我水平较低,这表明糖尿病状况显著影响了她们执行这项任务的感知能力。补充信息:在线版本提供补充资料,网址为10.1007/s13340-025-00813-1。
{"title":"Exploring the association between self-efficacy for locomotor function and diabetes status in older females: a pilot study.","authors":"Fumiya Aizawa, Toshihiro Kawae, Akihiro Kakuda, Tomoyasu Ishiguro, Nobuichi Kuribayashi, Junji Kobayashi","doi":"10.1007/s13340-025-00813-1","DOIUrl":"10.1007/s13340-025-00813-1","url":null,"abstract":"<p><strong>Introduction: </strong>Older adults with diabetes often experience a decline in locomotor functions, such as stair climbing and walking, which are important for activities of daily living (ADL). Furthermore, individuals with low Self-Efficacy for Locomotor Function (SELF) are at a higher risk of requiring locomotor assistance. This study explored the relationship between diabetes and SELF in older females.</p><p><strong>Methods: </strong>This study included 45 females (15 non-diabetes, 30 diabetes) aged 65 years and over without ADL impairment in our clinic. SELF was measured by walking and stair climbing. Physical function was measured by hand grip strength, knee extension force (KEF), and KEF divided by bodyweight (%KEF).</p><p><strong>Results: </strong>The SELF of stair climbing was significantly lower in the diabetes mellitus group than in the non-diabetes mellitus group (<i>p = </i>0.009), whereas the SELF of walking was not significantly different (<i>p = </i>0.351). Diabetes status remained a significant factor in the SELF of stair climbing after adjusting for body mass index, orthopedic disease, and %KEF.</p><p><strong>Discussion: </strong>Stair climbing is one of the most vigorous ADLs performed by older adults, and this result may be due to the fact that stair climbing is a more vigorous activity than walking. Furthermore, the results of this study suggest that other factors (physical function other than %KEF and handgrip strength, psychological factors) related to diabetes may be more important than %KEF in older females.</p><p><strong>Conclusions: </strong>SELF for stair climbing in older females was lower in those with diabetes, indicating that diabetes status significantly influenced their perceived ability to perform this task.</p><p><strong>Supplementary information: </strong>The online version contains supplementary material available at 10.1007/s13340-025-00813-1.</p>","PeriodicalId":11340,"journal":{"name":"Diabetology International","volume":"16 3","pages":"513-519"},"PeriodicalIF":1.3,"publicationDate":"2025-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12209083/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144552621","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Improving postprandial hyperglycemia in prediabetic, sedentary office workers with immediately post-lunch, intermediate-intensity exercise: a comprehensive evaluation using a physical activity tracker, a dietary management application, and continuous glucose monitoring. 改善糖尿病前期、久坐上班族午餐后立即进行中等强度运动的餐后高血糖:使用身体活动追踪器、饮食管理应用程序和连续血糖监测的综合评估
IF 1.3 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-03-22 eCollection Date: 2025-07-01 DOI: 10.1007/s13340-025-00812-2
Keiko Koide, Koichiro Azuma, Yoshihito Atsumi

Aim/introduction: This study investigated if immediately post-lunch exercise may improve postprandial hyperglycemia in individuals with prediabetes.

Materials and methods: The study consisted of a control phase involving no exercise and an exercise phase involving exercise. During both phases, participants were assessed for their AUC, RCMC and %TITR using CGM-derived postprandial data; they were also assessed for physical activity using a physical activity tracker and for energy intake using a dietary management application.

Results: Of the 43 males included, 23 were available for analysis. Their AUC values were significantly lower at post-lunch 1 h in the exercise phase than in the control phase with their %TITR values being significantly higher in the exercise phase than in the control phase. Their cumulative AUC values were significantly lower for post-lunch 2, 3, and 4 h in the exercise phase, with the cumulative %TITR values being also significantly higher. Their RCMC values were significantly lower for post-lunch 0-1 and 3-4 h, and significantly higher for post-lunch 1-2 h, in the exercise phase than in the control phase, with no difference for post-lunch 2-3 h between the phases. They exhibited monophasic or biphasic glucose profiles in the exercise phase with significantly different AUC and %TITR values for post-lunch 0-4 h, but no difference in HR reserve (HRR), energy intake or its composition.

Conclusion: In those with prediabetes, postprandial hyperglycemia improved with immediately post-lunch exercise, with significant improvements in cumulative AUC and %TITR values. Further study is required to clarify why they exhibited disparate glucose profiles.

目的/介绍:本研究调查了是否午饭后立即运动可以改善糖尿病前期患者的餐后高血糖。材料和方法:研究分为不运动的控制阶段和运动阶段。在这两个阶段,使用cgm衍生的餐后数据评估参与者的AUC、RCMC和%TITR;研究人员还使用身体活动追踪器对他们进行了身体活动评估,并使用饮食管理应用程序对他们的能量摄入进行了评估。结果:纳入的43名男性中,有23名可供分析。午休后1 h,运动阶段的AUC值显著低于对照组,运动阶段的%TITR值显著高于对照组。午休后2、3、4 h的累计AUC值显著低于午休后2、3、4 h,累计%TITR值显著高于午休后2、3、4 h的累计AUC值。运动阶段的RCMC值在午餐后0-1和3-4 h显著低于对照组,在午餐后1-2 h显著高于对照组,在午餐后2-3 h无显著差异。他们在运动阶段表现出单相或双相葡萄糖谱,午餐后0-4小时的AUC和%TITR值有显著差异,但HR储备(HRR)、能量摄入或其组成没有差异。结论:在糖尿病前期患者中,餐后高血糖通过午餐后立即运动得到改善,累积AUC和%TITR值有显著改善。需要进一步的研究来阐明为什么他们表现出不同的葡萄糖谱。
{"title":"Improving postprandial hyperglycemia in prediabetic, sedentary office workers with immediately post-lunch, intermediate-intensity exercise: a comprehensive evaluation using a physical activity tracker, a dietary management application, and continuous glucose monitoring.","authors":"Keiko Koide, Koichiro Azuma, Yoshihito Atsumi","doi":"10.1007/s13340-025-00812-2","DOIUrl":"10.1007/s13340-025-00812-2","url":null,"abstract":"<p><strong>Aim/introduction: </strong>This study investigated if immediately post-lunch exercise may improve postprandial hyperglycemia in individuals with prediabetes.</p><p><strong>Materials and methods: </strong>The study consisted of a control phase involving no exercise and an exercise phase involving exercise. During both phases, participants were assessed for their AUC, RCMC and %TITR using CGM-derived postprandial data; they were also assessed for physical activity using a physical activity tracker and for energy intake using a dietary management application.</p><p><strong>Results: </strong>Of the 43 males included, 23 were available for analysis. Their AUC values were significantly lower at post-lunch 1 h in the exercise phase than in the control phase with their %TITR values being significantly higher in the exercise phase than in the control phase. Their cumulative AUC values were significantly lower for post-lunch 2, 3, and 4 h in the exercise phase, with the cumulative %TITR values being also significantly higher. Their RCMC values were significantly lower for post-lunch 0-1 and 3-4 h, and significantly higher for post-lunch 1-2 h, in the exercise phase than in the control phase, with no difference for post-lunch 2-3 h between the phases. They exhibited monophasic or biphasic glucose profiles in the exercise phase with significantly different AUC and %TITR values for post-lunch 0-4 h, but no difference in HR reserve (HRR), energy intake or its composition.</p><p><strong>Conclusion: </strong>In those with prediabetes, postprandial hyperglycemia improved with immediately post-lunch exercise, with significant improvements in cumulative AUC and %TITR values. Further study is required to clarify why they exhibited disparate glucose profiles.</p>","PeriodicalId":11340,"journal":{"name":"Diabetology International","volume":"16 3","pages":"504-512"},"PeriodicalIF":1.3,"publicationDate":"2025-03-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12209051/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144552622","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Renal function trajectories of Japanese adults with diabetic kidney disease on different diet therapies including energy-restricted and low-carbohydrate diets: a retrospective cohort study. 日本成年糖尿病肾病患者在不同饮食疗法(包括能量限制饮食和低碳水化合物饮食)下的肾功能轨迹:一项回顾性队列研究
IF 1.3 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-03-21 eCollection Date: 2025-07-01 DOI: 10.1007/s13340-025-00808-y
Tomomi Shirai, Sakiko Inaba, Miyu Maemura, Maki Saho, Miyu Sato, Mariko Sanada, Yoko Tsukamoto, Gaku Inoue, Taichi Nagahisa, Shinichi Tanaka, Hajime Tanaka, Hideaki Kurata, Takeshi Katsuki, Toshihide Kawai, Satoru Yamada

Objective: Recently, the Japan Diabetes Society changed its nutrition recommendations and now recognizes a low-carbohydrate diet as an effective dietary approach. There has been controversy regarding low-carbohydrate diets in relation to renal function. That is, high protein intake may lead to renal damage through hyperfiltration. Global nutritional therapy for diabetic kidney disease (DKD) recommends a protein intake of 0.8 g/kg body weight (BW)/day. In Japan, the recommended protein intake is precisely determined based on the chronic kidney disease stage. However, evidence supporting the positive health impact of such protein restriction is scarce. Therefore, we aimed to investigate the effect of a low-carbohydrate diet without protein restriction on the estimated glomerular filtration rate (eGFR) decline rate.

Methods: Clinical data of patients with DKD in Tokyo Saiseikai Central Hospital and Kitasato Institute Hospital in Japan were retrospectively analyzed between February 2019 and December 2023. Sixty-eight participants were classified into two groups based on their diet: the energy-restricted and low-carbohydrate groups.

Results: The protein intake of the low-carbohydrate group was significantly higher than that of the energy-restricted group (1.2 ± 0.4 and 1.0 ± 0.2 g/kg BW/day, respectively). No significant differences were observed in the baseline, endpoint, or slope of eGFR between the two groups.

Conclusions: This study suggests that among Japanese adults with DKD, the protein intake difference between energy-restricted and low-carbohydrate diets does not form any gap in eGFR decline rates.

Supplementary information: The online version contains supplementary material available at 10.1007/s13340-025-00808-y.

目的:最近,日本糖尿病学会改变了其营养建议,现在承认低碳水化合物饮食是一种有效的饮食方法。关于低碳水化合物饮食与肾功能的关系一直存在争议。也就是说,高蛋白摄入可能通过超滤导致肾脏损害。全球糖尿病肾病营养疗法(DKD)建议蛋白质摄入量为0.8 g/kg体重(BW)/天。在日本,推荐的蛋白质摄入量是根据慢性肾脏疾病的阶段精确确定的。然而,支持这种蛋白质限制对健康的积极影响的证据很少。因此,我们旨在研究无蛋白质限制的低碳水化合物饮食对肾小球滤过率(eGFR)下降率的影响。方法:回顾性分析2019年2月至2023年12月日本东京生成会中心医院和北内研究所医院DKD患者的临床资料。68名参与者根据饮食被分为两组:能量限制组和低碳水化合物组。结果:低碳水化合物组蛋白质摄取量显著高于能量限制组(分别为1.2±0.4和1.0±0.2 g/kg BW/d)。两组之间eGFR的基线、终点或斜率均无显著差异。结论:本研究表明,在患有DKD的日本成年人中,能量限制饮食和低碳水化合物饮食之间的蛋白质摄入量差异不会对eGFR下降率产生任何影响。补充信息:在线版本包含补充资料,提供地址为10.1007/s13340-025-00808-y。
{"title":"Renal function trajectories of Japanese adults with diabetic kidney disease on different diet therapies including energy-restricted and low-carbohydrate diets: a retrospective cohort study.","authors":"Tomomi Shirai, Sakiko Inaba, Miyu Maemura, Maki Saho, Miyu Sato, Mariko Sanada, Yoko Tsukamoto, Gaku Inoue, Taichi Nagahisa, Shinichi Tanaka, Hajime Tanaka, Hideaki Kurata, Takeshi Katsuki, Toshihide Kawai, Satoru Yamada","doi":"10.1007/s13340-025-00808-y","DOIUrl":"10.1007/s13340-025-00808-y","url":null,"abstract":"<p><strong>Objective: </strong>Recently, the Japan Diabetes Society changed its nutrition recommendations and now recognizes a low-carbohydrate diet as an effective dietary approach. There has been controversy regarding low-carbohydrate diets in relation to renal function. That is, high protein intake may lead to renal damage through hyperfiltration. Global nutritional therapy for diabetic kidney disease (DKD) recommends a protein intake of 0.8 g/kg body weight (BW)/day. In Japan, the recommended protein intake is precisely determined based on the chronic kidney disease stage. However, evidence supporting the positive health impact of such protein restriction is scarce. Therefore, we aimed to investigate the effect of a low-carbohydrate diet without protein restriction on the estimated glomerular filtration rate (eGFR) decline rate.</p><p><strong>Methods: </strong>Clinical data of patients with DKD in Tokyo Saiseikai Central Hospital and Kitasato Institute Hospital in Japan were retrospectively analyzed between February 2019 and December 2023. Sixty-eight participants were classified into two groups based on their diet: the energy-restricted and low-carbohydrate groups.</p><p><strong>Results: </strong>The protein intake of the low-carbohydrate group was significantly higher than that of the energy-restricted group (1.2 ± 0.4 and 1.0 ± 0.2 g/kg BW/day, respectively). No significant differences were observed in the baseline, endpoint, or slope of eGFR between the two groups.</p><p><strong>Conclusions: </strong>This study suggests that among Japanese adults with DKD, the protein intake difference between energy-restricted and low-carbohydrate diets does not form any gap in eGFR decline rates.</p><p><strong>Supplementary information: </strong>The online version contains supplementary material available at 10.1007/s13340-025-00808-y.</p>","PeriodicalId":11340,"journal":{"name":"Diabetology International","volume":"16 3","pages":"493-503"},"PeriodicalIF":1.3,"publicationDate":"2025-03-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12209081/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144552632","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Minocycline reduces proinflammatory and oxidative stress markers in the spinal cord and morphology changes in sciatic nerve of Type 2 diabetic neuropathy rat model. 米诺环素降低2型糖尿病神经病变大鼠脊髓促炎和氧化应激标志物及坐骨神经形态学改变。
IF 1.3 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-03-19 eCollection Date: 2025-07-01 DOI: 10.1007/s13340-025-00811-3
Norhamidar Ab Hamid, Norsuhana Omar, Che Aishah Nazariah Ismail, Idris Long

Aim: This study investigated the effects of minocycline on proinflammatory cytokines, oxidative stress marker levels in the spinal cord and sciatic nerve morphology in Type 2 diabetic (T2DM) neuropathy rats.

Methods: Male Sprague Dawley rats were randomly assigned to six groups (n = 14 per groups): Control (C), T2DM control (STZ), T2DM treated with minocycline 40 mg/kg (STZ + M40) and 80 mg/kg (STZ + M80), T2DM treated with gabapentin (STZ + G10) and non-painful T2DM neuropathy (NPDN). T2DM was induced in obese rats using a combination of high fat diet (HFD) and low-dose streptozotocin (STZ) (40 mg/kg) injection. Then, the neuropathic pain behaviour, body weight and blood biochemical analysis were performed. Rats were sacrificed and the spinal cord and sciatic nerve were collected for ELISA and histology examination.

Results: T2DM rat groups were significantly increased body weight after 6 weeks but significantly reduced from 8 until 9 weeks compared to control group (p < 0.05). The fasting blood glucose (FBG) level in all T2DM groups were significantly higher on day 3, day 14, and day 22 compared to control group (p < 0.05) consistent with HbA1c levels. T2DM groups also significantly increased MDA, TNF-α, IL-1β and C-Reactive Protein (CRP) but decreased SOD and Catalase levels in the spinal cord compared to control group (p < 0.05). T2DM groups also showed significant abnormal morphology changes in the sciatic nerve compared to control group (p < 0.05). Minocycline dependent on doses and gabapentin in T2DM rat significantly alleviated all these effects.

Conclusion: These findings suggest the neuroprotective effects of minocycline on T2DM neuropathy.

目的:研究米诺环素对2型糖尿病(T2DM)神经病变大鼠脊髓促炎细胞因子、氧化应激标志物水平及坐骨神经形态学的影响。方法:雄性Sprague Dawley大鼠随机分为6组(每组n = 14):对照组(C)、T2DM对照组(STZ)、米诺环素40 mg/kg (STZ + M40)和80 mg/kg (STZ + M80)、加巴喷丁(STZ + G10)和非疼痛性T2DM神经病(NPDN)。采用高脂饮食(HFD)联合注射低剂量链脲佐菌素(STZ) (40 mg/kg)诱导肥胖大鼠T2DM。然后进行神经性疼痛行为、体重和血液生化分析。处死大鼠,采集脊髓和坐骨神经进行酶联免疫吸附试验和组织学检查。结果:T2DM组大鼠体重在6周后显著增加,而在8 ~ 9周显著降低(p p p p)。结论:提示二甲胺四环素对T2DM神经病变具有神经保护作用。
{"title":"Minocycline reduces proinflammatory and oxidative stress markers in the spinal cord and morphology changes in sciatic nerve of Type 2 diabetic neuropathy rat model.","authors":"Norhamidar Ab Hamid, Norsuhana Omar, Che Aishah Nazariah Ismail, Idris Long","doi":"10.1007/s13340-025-00811-3","DOIUrl":"10.1007/s13340-025-00811-3","url":null,"abstract":"<p><strong>Aim: </strong>This study investigated the effects of minocycline on proinflammatory cytokines, oxidative stress marker levels in the spinal cord and sciatic nerve morphology in Type 2 diabetic (T2DM) neuropathy rats.</p><p><strong>Methods: </strong>Male Sprague Dawley rats were randomly assigned to six groups (<i>n</i> = 14 per groups): Control (C), T2DM control (STZ), T2DM treated with minocycline 40 mg/kg (STZ + M40) and 80 mg/kg (STZ + M80), T2DM treated with gabapentin (STZ + G10) and non-painful T2DM neuropathy (NPDN). T2DM was induced in obese rats using a combination of high fat diet (HFD) and low-dose streptozotocin (STZ) (40 mg/kg) injection. Then, the neuropathic pain behaviour, body weight and blood biochemical analysis were performed. Rats were sacrificed and the spinal cord and sciatic nerve were collected for ELISA and histology examination.</p><p><strong>Results: </strong>T2DM rat groups were significantly increased body weight after 6 weeks but significantly reduced from 8 until 9 weeks compared to control group (<i>p</i> < 0.05). The fasting blood glucose (FBG) level in all T2DM groups were significantly higher on day 3, day 14, and day 22 compared to control group (<i>p</i> < 0.05) consistent with HbA1c levels. T2DM groups also significantly increased MDA, TNF-α, IL-1β and C-Reactive Protein (CRP) but decreased SOD and Catalase levels in the spinal cord compared to control group (<i>p</i> < 0.05). T2DM groups also showed significant abnormal morphology changes in the sciatic nerve compared to control group (<i>p</i> < 0.05). Minocycline dependent on doses and gabapentin in T2DM rat significantly alleviated all these effects.</p><p><strong>Conclusion: </strong>These findings suggest the neuroprotective effects of minocycline on T2DM neuropathy.</p>","PeriodicalId":11340,"journal":{"name":"Diabetology International","volume":"16 3","pages":"483-492"},"PeriodicalIF":1.3,"publicationDate":"2025-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12209144/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144552627","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Decoding MODY: exploring genetic roots and clinical pathways. 解码MODY:探索遗传根源和临床途径。
IF 1.3 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-03-14 eCollection Date: 2025-04-01 DOI: 10.1007/s13340-025-00809-x
Anshuman Phadnis, Diya Chawla, Joanne Alex, Pamela Jha

Purpose: Maturity-onset diabetes of the young (MODY) is a transformative factor in today's pattern of diabetes care. The definition of its genetic basis brings insight into the diabetes processes, opening up possibilities for its early detection through public health strategies and improvement in precision medicine. Current knowledge on MODY has been brought together in this review.

Methods: Extensive literature review on PubMed and Google Scholar databases was conducted. Studies encompassing (1) genetic underpinnings and their types, (2) the significance of its biomarkers, and (3) diagnostic techniques and treatment modalities were focused upon.

Results: The disease accounts for 1-2% of all cases of diabetes and is usually misdiagnosed as either Type 1 or Type 2 diabetes. Several genes are involved in the appropriate functioning of pancreatic β-cells and mutations in these genes lead to an impairment in glucose metabolism and insulin secretion. A mild degree of hyperglycaemia, but without ketosis, is typical of MODY, seen mostly in adolescents and young adults. Treatment varies, including sulfonylureas for HNF1A and HNF4A mutations, lifestyle management for GCK mutations, and emerging therapies like GLP1 receptor agonists.

Conclusion: Proper genetic diagnosis is cardinal to the best management of MODY. Genetic and clinical advances have been impressive in monogenic diabetes, but further research in novel therapies is needed to optimise outcomes with precision medicine.

目的:青年成熟型糖尿病(MODY)是当今糖尿病护理模式的一个变革性因素。对其遗传基础的定义使人们对糖尿病的发病过程有了更深入的了解,从而为通过公共卫生战略和改进精准医疗进行早期发现提供了可能性。本综述汇集了目前关于MODY的知识。方法:广泛查阅PubMed和谷歌Scholar数据库的文献。研究包括(1)遗传基础及其类型,(2)其生物标志物的意义,以及(3)诊断技术和治疗方式。结果:该病占所有糖尿病病例的1-2%,常被误诊为1型或2型糖尿病。几个基因参与胰腺β细胞的正常功能,这些基因的突变导致葡萄糖代谢和胰岛素分泌的损害。轻度高血糖,但无酮症,是MODY的典型症状,多见于青少年和青壮年。治疗方法多种多样,包括针对HNF1A和HNF4A突变的磺脲类药物,针对GCK突变的生活方式管理,以及GLP1受体激动剂等新兴疗法。结论:正确的遗传学诊断对MODY的最佳治疗至关重要。单基因糖尿病的遗传和临床进展令人印象深刻,但需要进一步研究新的治疗方法,以优化精准医疗的结果。
{"title":"Decoding MODY: exploring genetic roots and clinical pathways.","authors":"Anshuman Phadnis, Diya Chawla, Joanne Alex, Pamela Jha","doi":"10.1007/s13340-025-00809-x","DOIUrl":"10.1007/s13340-025-00809-x","url":null,"abstract":"<p><strong>Purpose: </strong>Maturity-onset diabetes of the young (MODY) is a transformative factor in today's pattern of diabetes care. The definition of its genetic basis brings insight into the diabetes processes, opening up possibilities for its early detection through public health strategies and improvement in precision medicine. Current knowledge on MODY has been brought together in this review.</p><p><strong>Methods: </strong>Extensive literature review on PubMed and Google Scholar databases was conducted. Studies encompassing (1) genetic underpinnings and their types, (2) the significance of its biomarkers, and (3) diagnostic techniques and treatment modalities were focused upon.</p><p><strong>Results: </strong>The disease accounts for 1-2% of all cases of diabetes and is usually misdiagnosed as either Type 1 or Type 2 diabetes. Several genes are involved in the appropriate functioning of pancreatic β-cells and mutations in these genes lead to an impairment in glucose metabolism and insulin secretion. A mild degree of hyperglycaemia, but without ketosis, is typical of MODY, seen mostly in adolescents and young adults. Treatment varies, including sulfonylureas for HNF1A and HNF4A mutations, lifestyle management for GCK mutations, and emerging therapies like GLP1 receptor agonists.</p><p><strong>Conclusion: </strong>Proper genetic diagnosis is cardinal to the best management of MODY. Genetic and clinical advances have been impressive in monogenic diabetes, but further research in novel therapies is needed to optimise outcomes with precision medicine.</p>","PeriodicalId":11340,"journal":{"name":"Diabetology International","volume":"16 2","pages":"257-271"},"PeriodicalIF":1.3,"publicationDate":"2025-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11954780/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143751581","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association of early onset gestational diabetes mellitus with postpartum glucose intolerance. 早发妊娠期糖尿病与产后葡萄糖耐受不良的关系。
IF 1.3 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-02-22 eCollection Date: 2025-04-01 DOI: 10.1007/s13340-025-00807-z
Akihito Morita, Ayuko Tanaka, Daisuke Higeta, Tatsuya Sato, Eijiro Yamada, Akira Iwase

Background: This study aimed to investigate the association between postpartum glucose intolerance and the timing of gestational diabetes mellitus (GDM) diagnosis according to criteria from the International Association of Diabetes and Pregnancy Study Groups (IADPSG).

Methods: A single-center retrospective case-control study involving patients diagnosed with GDM according to IADPSG criteria was conducted. Patients underwent a postpartum 75 g oral glucose tolerance test (OGTT) and were divided into 2 groups: normal (control) and abnormal glucose tolerance (AGT). Gestational age at GDM diagnosis and the maternal and neonatal outcomes were compared between the groups.

Results: Data from 177 controls and 102 patients diagnosed with AGT were analyzed. The AGT group exhibited a higher pre-pregnancy body mass index, family history of diabetes, glycated hemoglobin level at the initial visit, and total daily insulin dose, but a lower rate of GDM diagnosis at 24-32 weeks' gestation. GDM diagnosed before 24 weeks' gestation was independently associated with AGT (adjusted odds ratio 2.18 [95% confidence interval 1.28-3.73]; p < 0.01]). Additionally, a higher proportion of patients diagnosed with GDM before 24 weeks' gestation had a lower disposition index (27.1% versus 14.8%; p = 0.01).

Conclusions: Patients diagnosed with GDM at < 24 weeks' gestation were at higher risk for postpartum glucose intolerance than those diagnosed at 24-32 weeks. The lower disposition index in patients early diagnosed highlights the need for tailored postpartum follow-up to address their specific risks.

背景:本研究旨在根据国际糖尿病和妊娠研究小组协会(IADPSG)的标准,探讨产后葡萄糖耐受不良与妊娠期糖尿病(GDM)诊断时间的关系。方法:采用单中心回顾性病例对照研究,纳入按IADPSG标准诊断为GDM的患者。产后进行75 g口服糖耐量试验(OGTT),分为正常(对照组)和异常糖耐量(AGT)两组。比较两组间GDM诊断时的胎龄以及产妇和新生儿结局。结果:分析了177例对照组和102例诊断为AGT的患者的数据。AGT组孕前体重指数、糖尿病家族史、初次就诊时糖化血红蛋白水平和每日胰岛素总剂量较高,但妊娠24-32周时GDM诊出率较低。妊娠24周前诊断的GDM与AGT独立相关(调整优势比2.18[95%可信区间1.28-3.73];p p = 0.01)。结论:诊断为GDM的患者
{"title":"Association of early onset gestational diabetes mellitus with postpartum glucose intolerance.","authors":"Akihito Morita, Ayuko Tanaka, Daisuke Higeta, Tatsuya Sato, Eijiro Yamada, Akira Iwase","doi":"10.1007/s13340-025-00807-z","DOIUrl":"10.1007/s13340-025-00807-z","url":null,"abstract":"<p><strong>Background: </strong>This study aimed to investigate the association between postpartum glucose intolerance and the timing of gestational diabetes mellitus (GDM) diagnosis according to criteria from the International Association of Diabetes and Pregnancy Study Groups (IADPSG).</p><p><strong>Methods: </strong>A single-center retrospective case-control study involving patients diagnosed with GDM according to IADPSG criteria was conducted. Patients underwent a postpartum 75 g oral glucose tolerance test (OGTT) and were divided into 2 groups: normal (control) and abnormal glucose tolerance (AGT). Gestational age at GDM diagnosis and the maternal and neonatal outcomes were compared between the groups.</p><p><strong>Results: </strong>Data from 177 controls and 102 patients diagnosed with AGT were analyzed. The AGT group exhibited a higher pre-pregnancy body mass index, family history of diabetes, glycated hemoglobin level at the initial visit, and total daily insulin dose, but a lower rate of GDM diagnosis at 24-32 weeks' gestation. GDM diagnosed before 24 weeks' gestation was independently associated with AGT (adjusted odds ratio 2.18 [95% confidence interval 1.28-3.73]; <i>p</i> < 0.01]). Additionally, a higher proportion of patients diagnosed with GDM before 24 weeks' gestation had a lower disposition index (27.1% versus 14.8%; <i>p</i> = 0.01).</p><p><strong>Conclusions: </strong>Patients diagnosed with GDM at < 24 weeks' gestation were at higher risk for postpartum glucose intolerance than those diagnosed at 24-32 weeks. The lower disposition index in patients early diagnosed highlights the need for tailored postpartum follow-up to address their specific risks.</p>","PeriodicalId":11340,"journal":{"name":"Diabetology International","volume":"16 2","pages":"414-420"},"PeriodicalIF":1.3,"publicationDate":"2025-02-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11954781/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143751550","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association among the number of natural teeth, dental maintenance visits and diabetes status: a cross-sectional study using employment-based healthcare claims database. 天然牙齿数量、牙齿维护访问和糖尿病状况之间的关系:一项使用基于就业的医疗索赔数据库的横断面研究。
IF 1.3 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-02-20 eCollection Date: 2025-04-01 DOI: 10.1007/s13340-025-00805-1
Miki Ishikawa, Takako Yasuda, Natsuki Nara, Itsuko Miyazawa, Naoko Takase, Kayo Harada, Atsushi Ishikado, Katsutaro Morino

Aim: Although diabetes is associated with the risk of tooth loss, there are no large-scale studies examining the reality and the effectiveness of dental maintenance visits in preventing tooth loss. We aimed to investigate the associations among the number of teeth, dental maintenance visits and diabetic status.

Methods: This is a cross-sectional study: a database comprising employment-based health insurance claim and medical check-up data between April 2015 and March 2016. From the dental receipts for a total of 705,542 individuals aged 20-74 years, we calculated dental visits ratio. After excluding missing data on the number of teeth and HbA1c, the association between dental maintenance visits and the number of teeth was further examined in 185,820 individuals aged 40-69 years visited a dentist by diabetes status.

Results: The percentage of dental visits was 46% overall, particularly low among younger subjects (34% in 20 s, 43% in 30 s), and increased with age. The maintenance-included group had a higher number of teeth than the treatment-only group, even at older ages, and this association was observed regardless of diabetes or glycemic control status. Furthermore, even with diabetes, the number of teeth in the group with good glycemic control was like that of non-diabetic.

Conclusion: Dental visits ratio was particularly low among younger subjects and those who receive dental maintenance had a higher number of teeth, regardless of diabetes or not. Adequate glycemic control and dental maintenance were associated with the number of teeth in the people with diabetes. The results suggest that it is important for physicians to work closely with dentists to promote patient-centered care and encourage both maintenance visits and better glycemic control.

Supplementary information: The online version contains supplementary material available at 10.1007/s13340-025-00805-1.

目的:虽然糖尿病与牙齿脱落的风险有关,但目前还没有大规模的研究来检验牙齿维护访问在预防牙齿脱落方面的现实和有效性。我们的目的是调查牙齿数量、牙齿维护次数和糖尿病状态之间的关系。方法:这是一项横断面研究:一个数据库,包含2015年4月至2016年3月期间基于就业的健康保险索赔和体检数据。根据共705,542名20至74岁人士的牙科收据,我们计算了牙科就诊比率。在排除牙齿数量和糖化血红蛋白的缺失数据后,对185820名年龄在40-69岁、因糖尿病而就诊的患者进行了牙齿维护就诊和牙齿数量之间的关系进行了进一步研究。结果:总体看牙医的比例为46%,在年轻的受试者中特别低(20多岁为34%,30多岁为43%),并且随着年龄的增长而增加。包括维护的一组比只接受治疗的一组有更多的牙齿,即使是在年龄较大的时候,这种关联也被观察到,与糖尿病或血糖控制状态无关。此外,即使患有糖尿病,血糖控制良好组的牙齿数量也与非糖尿病组相同。结论:与是否患有糖尿病无关,年轻患者的牙齿就诊率较低,接受牙齿保养的患者的牙齿数量较多。适当的血糖控制和牙齿保养与糖尿病患者的牙齿数量有关。研究结果表明,医生与牙医密切合作,促进以病人为中心的护理,鼓励定期就诊和更好的血糖控制是很重要的。补充信息:在线版本提供补充资料,网址为10.1007/s13340-025-00805-1。
{"title":"Association among the number of natural teeth, dental maintenance visits and diabetes status: a cross-sectional study using employment-based healthcare claims database.","authors":"Miki Ishikawa, Takako Yasuda, Natsuki Nara, Itsuko Miyazawa, Naoko Takase, Kayo Harada, Atsushi Ishikado, Katsutaro Morino","doi":"10.1007/s13340-025-00805-1","DOIUrl":"10.1007/s13340-025-00805-1","url":null,"abstract":"<p><strong>Aim: </strong>Although diabetes is associated with the risk of tooth loss, there are no large-scale studies examining the reality and the effectiveness of dental maintenance visits in preventing tooth loss. We aimed to investigate the associations among the number of teeth, dental maintenance visits and diabetic status.</p><p><strong>Methods: </strong>This is a cross-sectional study: a database comprising employment-based health insurance claim and medical check-up data between April 2015 and March 2016. From the dental receipts for a total of 705,542 individuals aged 20-74 years, we calculated dental visits ratio. After excluding missing data on the number of teeth and HbA1c, the association between dental maintenance visits and the number of teeth was further examined in 185,820 individuals aged 40-69 years visited a dentist by diabetes status.</p><p><strong>Results: </strong>The percentage of dental visits was 46% overall, particularly low among younger subjects (34% in 20 s, 43% in 30 s), and increased with age. The maintenance-included group had a higher number of teeth than the treatment-only group, even at older ages, and this association was observed regardless of diabetes or glycemic control status. Furthermore, even with diabetes, the number of teeth in the group with good glycemic control was like that of non-diabetic.</p><p><strong>Conclusion: </strong>Dental visits ratio was particularly low among younger subjects and those who receive dental maintenance had a higher number of teeth, regardless of diabetes or not. Adequate glycemic control and dental maintenance were associated with the number of teeth in the people with diabetes. The results suggest that it is important for physicians to work closely with dentists to promote patient-centered care and encourage both maintenance visits and better glycemic control.</p><p><strong>Supplementary information: </strong>The online version contains supplementary material available at 10.1007/s13340-025-00805-1.</p>","PeriodicalId":11340,"journal":{"name":"Diabetology International","volume":"16 2","pages":"403-413"},"PeriodicalIF":1.3,"publicationDate":"2025-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11954757/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143751436","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Diabetology International
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1